Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.
about
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease
P2860
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@en
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@nl
type
label
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@en
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@nl
prefLabel
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@en
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@nl
P2860
P356
P1476
Targets and Mechanisms in Prev ...... h Immunomodulatory Treatments.
@en
P2093
M von Euler Chelpin
P2860
P304
P356
10.1111/SJI.12542
P577
2017-02-23T00:00:00Z